Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Jolles

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Advances in Therapy|June 18, 2011
Subcutaneous immunoglobulin replacement therapy with Hizentra, the first 20% SCIG preparation: a practical approachS Jolles, J W Sleasman
The British Journal of Dermatology|March 29, 2000
The treatment of atopic dermatitis with adjunctive high-dose intravenous immunoglobulin: a report of three patients and review of the literatureS Jolles, J Hughes, M Rustin
Journal of the American Academy of Dermatology|January 28, 1999
Intracellular interleukin-4 profiles during high-dose intravenous immunoglobulin treatment of therapy-resistant atopic dermatitisS Jolles, J Hughes, M Rustin
Clinical and Experimental Immunology|December 22, 2016
When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approachS Jolles, H Chapel, J Litzman
Archives of Dermatology|February 5, 1998
Dermatological uses of high-dose intravenous immunoglobulinS Jolles, J Hughes, S Whittaker
Immunology|December 4, 2002
Immunomodulatory action of intravenous immunoglobulinW A C Sewell, S Jolles
Journal of the American Academy of Dermatology|March 10, 1999
Therapeutic failure of high-dose intravenous immunoglobulin in pemphigus vulgarisS Jolles, J Hughes, M Rustin
The British Journal of Dermatology|May 8, 1999
Combination oral and topical tacrolimus in therapy-resistant pyoderma gangrenosumS Jolles, S Niclasse, E Benson
Clinical and Experimental Immunology|November 4, 2009
Intravenous immunoglobulins. Current understanding and future directionsS Jolles, S V Kaveri, J Orange
Drug Safety|March 30, 2000
Drug-induced aseptic meningitis: diagnosis and managementS Jolles, W A Sewell, C Leighton
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Advances in Therapy|June 18, 2011
Subcutaneous immunoglobulin replacement therapy with Hizentra, the first 20% SCIG preparation: a practical approachS Jolles, J W Sleasman
The British Journal of Dermatology|March 29, 2000
The treatment of atopic dermatitis with adjunctive high-dose intravenous immunoglobulin: a report of three patients and review of the literatureS Jolles, J Hughes, M Rustin
Journal of the American Academy of Dermatology|January 28, 1999
Intracellular interleukin-4 profiles during high-dose intravenous immunoglobulin treatment of therapy-resistant atopic dermatitisS Jolles, J Hughes, M Rustin
Clinical and Experimental Immunology|December 22, 2016
When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approachS Jolles, H Chapel, J Litzman
Archives of Dermatology|February 5, 1998
Dermatological uses of high-dose intravenous immunoglobulinS Jolles, J Hughes, S Whittaker
Immunology|December 4, 2002
Immunomodulatory action of intravenous immunoglobulinW A C Sewell, S Jolles
Journal of the American Academy of Dermatology|March 10, 1999
Therapeutic failure of high-dose intravenous immunoglobulin in pemphigus vulgarisS Jolles, J Hughes, M Rustin
The British Journal of Dermatology|May 8, 1999
Combination oral and topical tacrolimus in therapy-resistant pyoderma gangrenosumS Jolles, S Niclasse, E Benson
Clinical and Experimental Immunology|November 4, 2009
Intravenous immunoglobulins. Current understanding and future directionsS Jolles, S V Kaveri, J Orange
Drug Safety|March 30, 2000
Drug-induced aseptic meningitis: diagnosis and managementS Jolles, W A Sewell, C Leighton
Pageof 7